WHO. (2017) Depression and Other Common Mental Disorders: Global Health Estimates. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO.
GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137–50.
Article PubMed Central Google Scholar
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396:1204–22.
Arias-de la Torre J, Vilagut G, Ronaldson A, Serrano-Blanco A, Martín V, Peters M, Valderas JM, Dregan A, Alonso J. Prevalence and variability of current depressive disorder in 27 European countries: a population-based study. Lancet Public Health. 2021;6:e729–38.
Article PubMed PubMed Central Google Scholar
Kuehner C. Why is depression more common among women than among men? Lancet Psychiatry. 2017;4:146–58.
Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119–38.
Article PubMed PubMed Central Google Scholar
Weissman MM, Olfson M. Depression in women: implications for health care research. Science. 1995;269:799–801.
Article CAS PubMed Google Scholar
Abel KM, Freeman MP. Optimizing Mental Health for women: recognizing and treating Mood disorders throughout the Lifespan. J Clin Psychiatry. 2023. https://doi.org/10.4088/JCP.vtsmdd2136ahc.
Guo N, Robakis T, Miller C, Butwick A. Prevalence of Depression among women of Reproductive Age in the United States. Obstet Gynecol. 2018;131:671–9.
Article PubMed PubMed Central Google Scholar
Wisner KL, Sit DKY, McShea MC, et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry. 2013;70:490–8.
Article PubMed PubMed Central Google Scholar
Jahan N, Went TR, Sultan W, Sapkota A, Khurshid H, Qureshi IA, Alfonso M. Untreated depression during pregnancy and its effect on pregnancy outcomes. Syst Rev Cureus. 2021;13:e17251.
Weissman MM, Pilowsky DJ, Wickramaratne PJ, et al. Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA. 2006;295:1389–98.
Article CAS PubMed Google Scholar
Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009;48:143–57.
Article CAS PubMed PubMed Central Google Scholar
Singh HK, Saadabadi A. (2023) Sertraline. [Updated 2023 Feb 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK547689/
American Psychological Association. (2010) Publication manual of the American Psychological Association, 6th ed.
Kennedy SH, Lam RW, Mcintyre RS, et al. Canadian Psychiatric Association Association Des Psychiatres Du Canada the Canadian. J Psychiatry / La Revue Canadienne De Psychiatrie. 2016;61:540–60.
Bauer M, Pfennig A, Severus E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive disorders, Part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry. 2013;14:334–85.
National Institute for Health and Care Excellence. (2022) Depression in adults: treatment and management. London: National Institute for Health and Care Excellence (NICE); 2022 Jun 29. PMID: 35977056.
Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C. (2009) Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev CD006117.
Cuomo A, Maina G, Neal SM, et al. Using sertraline in postpartum and breastfeeding: balancing risks and benefits. Expert Opin Drug Saf. 2018;17:719–25.
Article CAS PubMed Google Scholar
Pinheiro E, Bogen DL, Hoxha D, Ciolino JD, Wisner KL. Sertraline and breastfeeding: review and meta-analysis. Arch Womens Ment Health. 2015;18:139–46.
Article PubMed PubMed Central Google Scholar
di Lanza T, Wisner KL. Antidepressant medication use during breastfeeding. Clin Obstet Gynecol. 2009;52:483–97.
Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL, Wisner KL. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry. 2004;161:1066–78.
American Psychiatric Association. (1980) Diagnostic and statistical manual of mental disorders (3rd Edition) (DSM-III). American Psychiatric Association, Washington DC.
American Psychiatric Association. Diagnostic and statistical Manual of Mental disorders. Revised (DSM-III-R)). American Psychiatric Association. 3rd ed. Washington DC: American Psychiatric; 1987.
Wichman CL, Stern TA. (2015) Diagnosing and treating Depression during pregnancy. Prim Care Companion CNS Disord. https://doi.org/10.4088/PCC.15F01776
Whitley H, Lindsey W. Sex-based differences in drug activity. Am Fam Physician. 2009;80:1254–8.
Moyer AM, Matey ET, Miller VM. Individualized medicine: sex, hormones, genetics, and adverse drug reactions. Pharmacol Res Perspect. 2019;7:e00541.
Article PubMed PubMed Central Google Scholar
Kornstein SG, Clayton AH, Bao W, Guico-Pabia CJ. A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women. J Womens Health (Larchmt). 2015;24:281–90.
Clayton AH, Kornstein SG, Dunlop BW, Focht K, Musgnung J, Ramey T, Bao W, Ninan PT. Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder. J Clin Psychiatry. 2013;74:1010–7.
Article CAS PubMed Google Scholar
Norman TR, Olver JS. Desvenlafaxine in the treatment of major depression: an updated overview. Expert Opin Pharmacother. 2021;22:1087–97.
Article CAS PubMed Google Scholar
Burt VK, Wohlreich MM, Mallinckrodt CH, Detke MJ, Watkin JG, Stewart DE. Duloxetine for the treatment of major depressive disorder in women ages 40 to 55 years. Psychosomatics. 2005;46:345–54.
Article CAS PubMed Google Scholar
Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren JL, Cohen LS. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. J Clin Psychiatry. 2003;64:473–9.
Article CAS PubMed Google Scholar
Zhou J, Wang X, Feng L, et al. Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study. BMC Psychiatry. 2021;21:260.
Article CAS PubMed PubMed Central Google Scholar
Mahajan SS, Tandon VR, Arora M, Mahajan A, Kotwal S. Comparative efficacy and Safety of Escitalopram versus Desvenlafaxine in Postmenopausal Women with Depression and anxiety: a randomized, Open-Label, comparative trial. J Midlife Health. 2019;10:141–6.
PubMed PubMed Central Google Scholar
Martényi F, Dossenbach M, Mraz K, Metcalfe S. Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile. Eur Neuropsychopharmacol. 2001;11:227–32.
Chu AWR. (2023) Selective Serotonin Reuptake Inhibitors. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK554406/
(2024) drugs.com/international/sertraline. In: https://www.drugs.com/international/sertraline.html
Dharmawardene V, Menkes DB. Psychotropic drugs in low-income countries. Lancet Psychiatry. 2014;1:490–2.
Gbadamosi IT, Henneh IT, Aluko OM, et al. Depression in Sub-saharan Africa. IBRO Neurosci Rep. 2022;12:309–22.
Article PubMed PubMed Central Google Scholar
Wemakor A, Casson K, Dolk H. Prevalence and sociodemographic patterns of antidepressant use among women of reproductive age: a prescription database study. J Affect Disord. 2014;167:299–305.
Sundell KA, Gissler M, Petzold M, W
留言 (0)